KCNA3 and COVID-19: We conducted in vitro experiments in healthy donor PBMCs to verify our findings on altered KCNA3, ORAI1, and STIM1 gene expression in dexamethasone-treated COVID-19 patients and confirmed that in vitro treatment with dexamethasone altered the abundance of these ion channel encoding genes.